pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLCpulmo-3017Research ArticleОБЗОРЫREVIEWФормотерол (форадил) в лечении хронической обструктивной болезни легких с позиций доказательной медициныFormoterol (foradil) in treatment of chronic obstructive pulmonary disease by evidence-based medicineЦойА. Н.TsoyA. N.АрхиповВ. В.ArkhipovV. V.Московская медицинская академия им. И.М.СеченоваRussian Federation20022610202104109112Copyright © Цой А.Н., Архипов В.В., 20212021Цой А.Н., Архипов В.В.Tsoy A.N., Arkhipov V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/3017
.
ReferencesBenhamou D., Cavelier V., Muir J.F. et al. Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil® Aerolizer™) with salbutamol (Ventodisk).Respir. Med. 2001; 95 (10). Web site: w w w .m dconsult.com .Benhamou D., Cavelier V., Muir J.F. et al. Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil® Aerolizer™) with salbutamol (Ventodisk).Respir. Med. 2001; 95 (10). Web site: w w w .m dconsult.com .Dahl R., Greefhorst A.P.M ., Nowak D. et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 164: 778-784.Dahl R., Greefhorst A.P.M ., Nowak D. et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 164: 778-784.Global initiative for chronic obstructive lung disease. National Heart, Lung, and Blood Institute. Publication Number 2701. March 2001.Global initiative for chronic obstructive lung disease. National Heart, Lung, and Blood Institute. Publication Number 2701. March 2001.Lotvall J. Pharmacological similarities and differences between beta2-agonists. Respir. Med. 2001; 95 (suppl.B). Web site: w ww.m dconsult.comLotvall J. Pharmacological similarities and differences between beta2-agonists. Respir. Med. 2001; 95 (suppl.B). Web site: w ww.m dconsult.comMario Cazzola М., Centanni S., Regorda C. et al. Onset of action of single doses of formoterol administered via turbuhaler in patients with stable COPD. Pulmon. Pharmacol. Ther. 2001; 14 (1). Web site: www.mdconsult.com.Mario Cazzola М., Centanni S., Regorda C. et al. Onset of action of single doses of formoterol administered via turbuhaler in patients with stable COPD. Pulmon. Pharmacol. Ther. 2001; 14 (1). Web site: www.mdconsult.com.Mosby's Drug Consult. Mosby's GenRx®, 2002, 12th ed. Версия для Internet. Web site: www.mdconsult.com.Mosby's Drug Consult. Mosby's GenRx®, 2002, 12th ed. Версия для Internet. Web site: www.mdconsult.com.Rossi A., Kristufek P., Levine B.E. et al. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. Chest 2002; 212 (4). Web site: www.mdconsult.comRossi A., Kristufek P., Levine B.E. et al. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. Chest 2002; 212 (4). Web site: www.mdconsult.com
The authors declare that there are no conflicts of interest present.